ArticleFrontiers in endocrinology2020

Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells.

Anna R Michmerhuizen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.